TherapeuticsMD, Inc.
TXMD
•Stock Analysis$1.25
+0.00 (+0.00%)• Live
TherapeuticsMD, Inc. Analysis Dashboard - Stock Analysis and Financial Metrics
Historical Prices
for TherapeuticsMD, Inc.
Key Financial Metrics
for TherapeuticsMD, Inc.
P/E Ratio
-6.60
Revenue Growth
+35.25%
EPS Growth
+65.45%
Market Cap
$0.01B
Dividend Yield
0.00%
Debt/Equity
0.22
ROIC
-13.12%
FCF Yield
+11.08%
View additional metrics
Valuation
P/B Ratio0.52
EV/Sales9.74
Financial Health
Current Ratio2.64
Return on Assets-6.16%
Analyst Recommendations
for TherapeuticsMD, Inc.
8 analysts
Consensus: Hold
About
for TherapeuticsMD, Inc.
Company Details
for TherapeuticsMD, Inc.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Marlan D. Walker
Employees
1
Market Cap
14.47M
Exchange
NASDAQ Global Select
IPO Date
May 9, 2007
Website
www.therapeuticsmd.comCIK
0000025743
ISIN
US88338N2062
CUSIP
88338N206
Country
US
Balance Sheet
for TherapeuticsMD, Inc.
Cash Flow Statement
for TherapeuticsMD, Inc.
Income Statement
for TherapeuticsMD, Inc.
News
No news available at the moment.